Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: FCF, FM
Subjects: INFARTO DO MIOCÁRDIO, NANOPARTÍCULAS, RATOS
ABNT
MARANHÃO, Raul Cavalcante et al. Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats. Atherosclerosis. Amsterdam: Elsevier. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2017.06.405. Acesso em: 19 abr. 2024. , 2017APA
Maranhão, R. C., Guido, M. C., Marques, A. F., Tavares, E. R., Bispo, D. L., Melo, M. D. T. de, et al. (2017). Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats. Atherosclerosis. Amsterdam: Elsevier. doi:10.1016/j.atherosclerosis.2017.06.405NLM
Maranhão RC, Guido MC, Marques AF, Tavares ER, Bispo DL, Melo MDT de, Lima AD, Nicolau JC, Salemi VM, Kalil Filho R. Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats [Internet]. Atherosclerosis. 2017 ; 263 e126.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.405Vancouver
Maranhão RC, Guido MC, Marques AF, Tavares ER, Bispo DL, Melo MDT de, Lima AD, Nicolau JC, Salemi VM, Kalil Filho R. Methotrexate carried in lipid core nanoparticles reduced the infarction size and improved left ventricle function following acute myocardium infarction induced in rats [Internet]. Atherosclerosis. 2017 ; 263 e126.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.405